These innovative molecules represent a significant progression in the management of type 2 diabetes. Retatrutide, a dual GLP-1 and GIP receptor agonist, demonstrates exceptional efficacy in controlling blood glucose https://poppyzowt219534.free-blogz.com/86417685/novel-glp-1-receptor-agonists-retatrutide-and-trizepatide